Skip to content

Efficacy and Safety of Troxipide extended release tablet in patients with gastritis and /or gastric ulcer

A Multi-centric, Randomized clinical trial to compare the efficacy and safety of Troxipide ER 300 mg and Troxipide IR 100 mg in the treatment of gastritis and /or gastric ulcer

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/07/002840
Enrollment
120
Registered
2012-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K25- Gastric ulcer Health Condition 2: K297- Gastritis, unspecified

Interventions

Intervention1: Troxipide ER 300mg: Troxipide 300 mg To be taken orally Once in a day for 28 days Control Intervention1: TRoxipide IR 100 mg: Troxipide 100 mg To be taken orally, Thrice in a day for 28

Sponsors

Dr Bhupesh Dewan
Lead Sponsor
Emcure Pharmaceuticals Ltd India
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female patients between 18-65 years of age. 2. Patients showing the presence of at least three subjective clinical symptoms of gastritis and/or gastric ulcer disease of mild to moderate severity (Refer page 15 for details on the clinical symptoms) 3. Patients willing to give written informed consent and willing to comply with trial protocol.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
â?¢ Proportion of patients achieving clinical symptom improvement at week 4 (four point score of at least 1 point lower than baseline score).Timepoint: 28 days

Secondary

MeasureTime frame
â?¢ Complete Clinical Resolution: Proportion of patients achieving a four point score of 1 at week 4Timepoint: 28 days;â?¢ Mean time for clinical symptom improvementTimepoint: 28 days;â?¢ Mean time for complete clinical resolutionTimepoint: 28 days;â?¢ Proportion of patients reporting favorable response to treatmentTimepoint: 28 days

Countries

India

Contacts

Public ContactDr Suresh Jain

Digestive Endoscopy Clinic & A Day Care Centre

scjdr@yahoo.com9822335381

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026